Michela Di Criscio
PhD student at Institutionen för organismbiologi; Fysiologi och miljötoxikologi
- Visiting address:
- Evolutionsbiologiskt Centrum EBC
Norbyvägen 18 A - Postal address:
- Norbyvägen 18 A
752 36 Uppsala
More information is available to staff who log in.
Short presentation
PhD candidate - EpiTox group (Prof. Joëlle Rüegg)
Increasing evidence shows developmental and multigenerational effects of Endocrine Disrupting Chemicals, which are chemicals that interfere with the endocrine system. Within the context of EDC exposure, my PhD aims to elucidate epigenetic marks and mechanisms that underlie changes in brain development and behavior. This will be achieved with genome-wide and targeted DNA and RNA methylation analyses as well as the use of animal and cell models.
Keywords
- brain development
- dna methylation
- embryonic stem cells
- endocrine disruptors
- epigenetics
- molecular toxicology
- neurodevelopment
- rna methylation
- toxicology
- transgenerational epigenetic inheritance
- zebrafish
Publications
Recent publications
- A human-relevant mixture of endocrine disrupting chemicals induces changes in hippocampal DNA methylation correlating with hyperactive behavior in male mice (2023)
- Present and future challenges for the investigation of transgenerational epigenetic inheritance (2023)
- Pilot survey reveals ophidiomycosis in dice snakes Natrix tessellata from Lake Garda, Italy (2023)
- Bisphenol A Inhibits the Transporter Function of the Blood-Brain Barrier by Directly Interacting with the ABC Transporter Breast Cancer Resistance Protein (BCRP) (2021)
All publications
Articles
- A human-relevant mixture of endocrine disrupting chemicals induces changes in hippocampal DNA methylation correlating with hyperactive behavior in male mice (2023)
- Present and future challenges for the investigation of transgenerational epigenetic inheritance (2023)
- Pilot survey reveals ophidiomycosis in dice snakes Natrix tessellata from Lake Garda, Italy (2023)
- Bisphenol A Inhibits the Transporter Function of the Blood-Brain Barrier by Directly Interacting with the ABC Transporter Breast Cancer Resistance Protein (BCRP) (2021)
